HMGB3P1: A Protein with Potential as A Drug Target Or Biomarker

Target Name: HMGB3P1

NCBI ID: G128872

HMGB3P1

Other Name(s): HMGB3L1 | High mobility group box 3 pseudogene 1 | HMG4L | high mobility group box 3 pseudogene 1 | dJ18C9.3

HMGB3P1: A Protein with Potential as A Drug Target Or Biomarker

HMGB3P1 (HMGB3-like protein 1) is a protein that is expressed in various tissues throughout the body, including the heart, liver, and kidneys. It is a member of the HMB family of proteins, which are known for their role in regulating cell signaling and inflammation.

One of the unique features of HMGB3P1 is its ability to interact with other proteins, particularly the transcription factor SMAD4. This interaction allows HMGB3P1 to regulate the activity of SMAD4, which is a key regulator of gene expression and DNA damage repair.

By interacting with SMAD4, HMGB3P1 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. This suggests that HMGB3P1 may be a potential drug target or biomarker for a variety of diseases.

One potential mechanism by which HMGB3P1 could be targeted by drugs is through its interaction with SMAD4. By inhibiting the activity of SMAD4, drugs could potentially disrupt the regulation of gene expression and DNA damage repair that is caused by this interaction. This could lead to a variety of potential therapeutic effects, including the inhibition of cancer growth and the regulation of autoimmune diseases.

Another potential mechanism by which HMGB3P1 could be targeted by drugs is through its role in the regulation of inflammation. HMGB3P1 has been shown to play a role in the regulation of inflammatory responses, and drugs that can disrupt this regulation could potentially be effective in treating a variety of inflammatory disorders.

In addition to its potential therapeutic applications, HMGB3P1 also has potential as a biomarker for a variety of diseases. Its interaction with SMAD4 and its role in the regulation of cellular processes make it an attractive candidate for use as a diagnostic or predictive marker for a variety of diseases.

Overall, HMGB3P1 is a protein that has significant potential as a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic or diagnostic agent.

Protein Name: High Mobility Group Box 3 Pseudogene 1

The "HMGB3P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HMGB3P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets